March 03, 2015 8:00 AM ET


Company Overview of X-Ceptor Therapeutics, Inc.

Company Overview

X-Ceptor Therapeutics, Inc. discovers and develops novel small molecule therapeutics that modulate nuclear receptors. The company offers drug discovery platform for the nuclear receptor gene family; and drug candidates to treat cardiovascular and metabolic disorders. The company was incorporated in 1999 and is based in San Diego, California. As of October 18, 2004, X-Ceptor Therapeutics, Inc. operates as a subsidiary of Exelixis, Inc.

4757 Nexus Centre Drive

Suite 200

San Diego, CA 92121

United States

Founded in 1999





Key Executives for X-Ceptor Therapeutics, Inc.

X-Ceptor Therapeutics, Inc. does not have any Key Executives recorded.

Similar Private Companies By Industry

Company Name Region
Scantibodies Laboratory, Inc. United States
Epigenomics, Inc. United States
Innovative Wheat Genetics United States
Durata Therapeutics, Inc. United States
Transfusion & Transplantation Technologies, Inc. United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact X-Ceptor Therapeutics, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at